133 related articles for article (PubMed ID: 10630103)
1. [Preparation of ketamine tablets for treatment of patients with neuropathic pain].
Yanagihara Y; Ohtani M; Matsumoto M; Kariya S; Uchino K; Hiraishi T; Ashizawa N; Aoyama T; Yamamura Y; Iga T
Yakugaku Zasshi; 1999 Dec; 119(12):980-7. PubMed ID: 10630103
[TBL] [Abstract][Full Text] [Related]
2. Ketamine for pain: an update of uses in palliative care.
Prommer EE
J Palliat Med; 2012 Apr; 15(4):474-83. PubMed ID: 22500483
[TBL] [Abstract][Full Text] [Related]
3. Perioperative ketamine does not prevent chronic pain after thoracotomy.
Dualé C; Sibaud F; Guastella V; Vallet L; Gimbert YA; Taheri H; Filaire M; Schoeffler P; Dubray C
Eur J Pain; 2009 May; 13(5):497-505. PubMed ID: 18783971
[TBL] [Abstract][Full Text] [Related]
4. Development of a sublingual/oral formulation of ketamine for use in neuropathic pain: Preliminary findings from a three-way randomized, crossover study.
Chong C; Schug SA; Page-Sharp M; Jenkins B; Ilett KF
Clin Drug Investig; 2009; 29(5):317-24. PubMed ID: 19366273
[TBL] [Abstract][Full Text] [Related]
5. Intravenous Ketamine Infusions for Neuropathic Pain Management: A Promising Therapy in Need of Optimization.
Maher DP; Chen L; Mao J
Anesth Analg; 2017 Feb; 124(2):661-674. PubMed ID: 28067704
[TBL] [Abstract][Full Text] [Related]
6. Chiral Pharmacokinetics and Metabolite Profile of Prolonged-release Ketamine Tablets in Healthy Human Subjects.
Hasan M; Modess C; Roustom T; Dokter A; Grube M; Link A; Rey H; Adler S; Meissner K; Siegmund W
Anesthesiology; 2021 Aug; 135(2):326-339. PubMed ID: 34019627
[TBL] [Abstract][Full Text] [Related]
7. [Analgesic effect of ketamine in a patient with neuropathic pain].
Oye I; Rabben T; Fagerlund TH
Tidsskr Nor Laegeforen; 1996 Oct; 116(26):3130-1. PubMed ID: 8999575
[TBL] [Abstract][Full Text] [Related]
8. Dissociative and Analgesic Properties of Ketamine Are Independent.
Gitlin J; Chamadia S; Locascio JJ; Ethridge BR; Pedemonte JC; Hahm EY; Ibala R; Mekonnen J; Colon KM; Qu J; Akeju O
Anesthesiology; 2020 Nov; 133(5):1021-1028. PubMed ID: 32898213
[TBL] [Abstract][Full Text] [Related]
9. High-Dose Ketamine Infusion for Neuropathic Pain in Critical Care Settings.
Parthvi R; Porhomayon J
Am J Ther; 2019; 26(6):e783-e784. PubMed ID: 31567174
[No Abstract] [Full Text] [Related]
10. Topical amitriptyline and ketamine for the treatment of neuropathic pain.
Mercadante S
Expert Rev Neurother; 2015; 15(11):1249-53. PubMed ID: 26488799
[TBL] [Abstract][Full Text] [Related]
11. Ketamine for Pain Management: A Review of Literature and Clinical Application.
Caruso K; Tyler D; Lyden A
Orthop Nurs; 2021 May-Jun 01; 40(3):189-193. PubMed ID: 34004619
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of oral ketamine for the relief of intractable chronic pain: A retrospective 5-year study of 51 patients.
Marchetti F; Coutaux A; Bellanger A; Magneux C; Bourgeois P; Mion G
Eur J Pain; 2015 Aug; 19(7):984-93. PubMed ID: 25381898
[TBL] [Abstract][Full Text] [Related]
13. [Preparing oral dosage form of ketamine in the hospital for simplicity and patient compliance--preparations using agar].
Kaneuchi M; Kohri N; Senbongi K; Sakai H; Iseki K
Yakugaku Zasshi; 2005 Feb; 125(2):187-96. PubMed ID: 15684573
[TBL] [Abstract][Full Text] [Related]
14. Ketamine PCA for treatment of end-of-life neuropathic pain in pediatrics.
Taylor M; Jakacki R; May C; Howrie D; Maurer S
Am J Hosp Palliat Care; 2015 Dec; 32(8):841-8. PubMed ID: 25028743
[TBL] [Abstract][Full Text] [Related]
15. Effects of low-dose intranasal (S)-ketamine in patients with neuropathic pain.
Huge V; Lauchart M; Magerl W; Schelling G; Beyer A; Thieme D; Azad SC
Eur J Pain; 2010 Apr; 14(4):387-94. PubMed ID: 19733106
[TBL] [Abstract][Full Text] [Related]
16. Continuous intravenous infusion of ketamine and lidocaine as adjuvant analgesics in a 5-year-old patient with neuropathic cancer pain.
Kajiume T; Sera Y; Nakanuno R; Ogura T; Karakawa S; Kobayakawa M; Taguchi S; Oshita K; Kawaguchi H; Sato T; Kobayashi M
J Palliat Med; 2012 Jun; 15(6):719-22. PubMed ID: 22401313
[TBL] [Abstract][Full Text] [Related]
17. Plasma concentration profiles of ketamine and norketamine after administration of various ketamine preparations to healthy Japanese volunteers.
Yanagihara Y; Ohtani M; Kariya S; Uchino K; Hiraishi T; Ashizawa N; Aoyama T; Yamamura Y; Yamada Y; Iga T
Biopharm Drug Dispos; 2003 Jan; 24(1):37-43. PubMed ID: 12516077
[TBL] [Abstract][Full Text] [Related]
18. Can gradual dose titration of ketamine for management of neuropathic pain prevent psychotomimetic effects in patients with advanced cancer?
Okamoto Y; Tsuneto S; Tanimukai H; Matsuda Y; Ohno Y; Tsugane M; Uejima E
Am J Hosp Palliat Care; 2013 Aug; 30(5):450-4. PubMed ID: 22833552
[TBL] [Abstract][Full Text] [Related]
19. Intrathecal ketamine and pregabalin at sub-effective doses synergistically reduces neuropathic pain without motor dysfunction in mice.
Lim HS; Kim JM; Choi JG; Ko YK; Shin YS; Jeon BH; Park JB; Lee JH; Kim HW
Biol Pharm Bull; 2013; 36(1):125-30. PubMed ID: 23302645
[TBL] [Abstract][Full Text] [Related]
20. Long-term stability of ketamine hydrochloride 50mg/ml injection in 3ml syringes.
Huvelle S; Godet M; Hecq JD; Gillet P; Bihin B; Jamart J; Galanti L
Ann Pharm Fr; 2016 Jul; 74(4):283-7. PubMed ID: 27107463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
